(Q48448124)

11 February 2018

title

Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas. (English)

1 reference

11 February 2018

0 references

K Gousias

1

1 reference

11 February 2018

A J Becker

series ordinal

2

1 reference

11 February 2018

M Simon

series ordinal

3

1 reference

11 February 2018

P Niehusmann

series ordinal

4

1 reference

11 February 2018

publication date

7 July 2012

1 reference

11 February 2018

Journal of Neuro-Oncology

published in

1 reference

11 February 2018

volume

109

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

545-553

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-012-0924-2

exact match

0 references

cites work

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Molecular markers in low-grade gliomas: predictive or prognostic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Karyopherin-alpha2 protein interacts with Chk2 and contributes to its nuclear import.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Importin KPNA2, NBS1, DNA repair and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Nijmegen breakage syndrome and functions of the responsible protein, NBS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0924-2

KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situ

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22772608

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22772608

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22772608

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-012-0924-2

1 reference

11 February 2018

PubMed ID

22772608

1 reference

11 February 2018